Mutations in GNAS have been documented in mucinous [32], clear cell, and serous [27] advanced ovarian cancers; thus, our findings in the endometrioid ovarian cancer subtype should be considered as a very infrequent somatic mutational event. The gene discussed is GNAS; the disease is ovarian endometrioid adenocarcinoma.